Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development

J Finne, M Leinonen, P H Mäkelä

    Lancet (London, England)
    |August 13, 1983
    PubMed
    Summary

    Human and rat brain glycopeptides with polysialic acid cross-react with antibodies to meningococcus group B. This cross-reactivity may hinder vaccine development and impact meningitis pathogenesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Periodontopathogen- and host-derived immune response in acute coronary syndrome.

    Scandinavian journal of immunology·2011
    Same author

    The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 birth cohort study.

    European psychiatry : the journal of the Association of European Psychiatrists·2011
    Same author

    The association of body mass index, waist and hip circumference, and waist-hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966.

    International journal of obesity (2005)·2011
    Same author

    Interleukin-6-174 G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men.

    Scandinavian journal of immunology·2011
    Same author

    Very high quantitative tumor HER2 content and outcome in early breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011
    Same author

    Nasopharyngeal bacterial colonization during the first wheezing episode is associated with longer duration of hospitalization and higher risk of relapse in young children.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2010

    Area of Science:

    • Neuroscience
    • Immunology
    • Microbiology

    Background:

    • Polysialic acid (PSA) is a component of bacterial capsules, including Neisseria meningitidis group B and Escherichia coli K1.
    • PSA plays a role in bacterial pathogenesis and immune evasion.
    • The human and rat brain contain endogenous PSA-containing molecules.

    Purpose of the Study:

    • To investigate the immunological cross-reactivity between brain-derived PSA and bacterial PSA.
    • To explore the implications of this cross-reactivity for vaccine development and meningitis pathogenesis.

    Main Methods:

    • Isolation of glycopeptides containing polysialic acid units from human and rat brain.
    • Testing the reactivity of these glycopeptides with antibodies against meningococcal capsules.

    Related Experiment Videos

  • Inhibition assays using capsular polysaccharides from different bacterial strains.
  • Main Results:

    • Polysialosyl glycopeptides from the brain specifically bound to antibodies against meningococcus group B.
    • This binding was inhibited by capsular polysaccharides from meningococcus group B and Escherichia coli K1.
    • Binding was not inhibited by polysaccharides from meningococcus groups A or C.

    Conclusions:

    • A cross-reactive antigen exists between bacterial PSA (meningococcus B, E. coli K1) and brain components.
    • This cross-reactivity may explain the challenges in developing effective vaccines against these bacteria.
    • Immunological tolerance to this cross-reactive antigen could be a factor in meningitis pathogenesis.
    • Caution is advised for vaccine development and antibody-based immunotherapy due to this cross-reactivity.